2015 Bridging Biomedical Worlds Conference
From Neural Circuitry to Neurotechnology
May 11-12, 2015, Tokyo
The 2015 Bridging Biomedical Worlds conference, entitled From neural circuitry to neurotechnology, was held in Tokyo, Japan, May 11-13, 2015, and was jointly organized by Fondation IPSEN, AAAS/Science and AAAS/Science Translational Medicine, and the RIKEN Brain Science Institute.
This year’s meeting, held in Tokyo, Japan, brings together an international roster of electrophysiologists, geneticists, molecular biologists, brain imaging experts, and clinical researchers.
Talks will highlight exciting, on-going research to better understand the basic building blocks of neural circuits, the mechanisms underlying their formation, and to translate this knowledge into safe and effective therapeutic applications. The meeting will cover a broad range of topics including memory formation, decision making, sensory systems, circuits for complex behavior, and new neurotechnologies.
We would like to take this opportunity to thank you all for being an important part of Bridging Biomedical Worlds 2015 and we hope you enjoy the meeting.
Susumu Tonegawa, 1987 Nobel prize laureate
ANDERSON David J.
(The Neurobiology of Emotional Behavior, California Institute of Technology, Pasadena, USA)
(Department of Molecular & Cell Biology, University of California, Berkeley, Berkeley, USA)
(Unité INSERM-CEA de Neuro-Imagerie Cognitive, Gif sur Yvette, France)
(Harvard University, Cambridge, USA)
(Institute of Neurosciences, Shangai Instit.for Biological Sciences, Chinese Academy Sciences, Shanghai, China)
(Neurosciences and Mental Health, Hospital For Sick Children Research Institute, Toronto Ontario, Canada)
KULLMANN Dimitri M.
(Institute of Neurology, University College London, London, UK)
(Friedrich Miescher Instit for Biomedical Research, Basel, Switzerland)
MAYBERG Helen S.
(Psychiatric Neuroimaging and Therapeutics, Emory University, Atlanta, USA)
(Department of Physiology, School of Medicine, The University of Tokyo, Tokyo, Japan)
(Laboratory for Cell Function Dynamics, RIKEN Brain Science Institute, Saitama, Japan)
(Departments of Molecular Neurogenetics, Max Planck Institute for Medical Research, Frankfurt am Main, Germany)
(Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK)
(Institut de la Vision, Centre Hospitalier Nat. d’Ophtalmologie des Quinze-Vingts, Paris, France)
SCHWARTZ Andrew B.
(Department of Neurobiology, University of Pittsburgh, Pittsburgh, USA)